Search

everythinglearnresearchcommunity

for

Search:↓

People with PCOS often have skin problems like excessive hair growth, hair loss, acne, and dark patches, which are linked to hormonal and metabolic imbalances.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

The document explains how male reproductive hormones work and affect the body.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Early hair loss in young males may not be clearly linked to insulin resistance or metabolic syndrome.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

High testosterone increases heart disease risk in women with PCOS.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

Testosterone therapy increases bone density in older men with low testosterone levels.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Testosterone with or without finasteride doesn't improve thinking skills in older men with low testosterone.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.